Find in Library

Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris®) for the treatment of severe sepsis in adults: a systematic review and economic evaluation

oleh: C Green, J Dinnes, A Takeda, J Shepherd, D Hartwell, C Cave, E Payne, B Cuthbertson